Hernberg MM - Search Results

1

Metastatic uveal melanoma managed with best supportive care.

Rantala ES, Hernberg MM, Lundin M, Lundin J, Kivelä TT. Rantala ES, et al. Among authors: hernberg mm. Acta Oncol. 2021 Jan;60(1):135-139. doi: 10.1080/0284186X.2020.1817978. Epub 2020 Sep 22. Acta Oncol. 2021. PMID: 32960119 No abstract available.

2

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma.

Vihinen PP, Hernberg M, Vuoristo MS, Tyynelä K, Laukka M, Lundin J, Ivaska J, Pyrhönen S. Vihinen PP, et al. Melanoma Res. 2010 Aug;20(4):318-25. doi: 10.1097/CMR.0b013e3283390365. Melanoma Res. 2010. PMID: 20375744 Clinical Trial.

3

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, Stierner U, Pyrhönen S, Syrjänen K, Lundin J, Hernberg M. Vihinen P, et al. Cancer Immunol Immunother. 2015 Feb;64(2):173-80. doi: 10.1007/s00262-014-1620-1. Epub 2014 Oct 16. Cancer Immunol Immunother. 2015. PMID: 25319807 Free PMC article. Clinical Trial.

4

Selective internal radiation therapy (SIRT) as treatment for hepatic metastases of uveal melanoma: a Finnish nation-wide retrospective experience.

Tulokas S, Mäenpää H, Peltola E, Kivelä T, Vihinen P, Virta A, Mäkelä S, Kallio R, Hernberg M. Tulokas S, et al. Acta Oncol. 2018 Oct;57(10):1373-1380. doi: 10.1080/0284186X.2018.1465587. Epub 2018 Apr 23. Acta Oncol. 2018. PMID: 29683787

5

Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis.

Rantala ES, Hernberg M, Kivelä TT. Rantala ES, et al. Melanoma Res. 2019 Dec;29(6):561-568. doi: 10.1097/CMR.0000000000000575. Melanoma Res. 2019. PMID: 30664106 Free PMC article.

6

Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.

Mattila KE, Vihinen P, Ramadan S, Skyttä T, Tiainen L, Vuoristo MS, Tyynelä-Korhonen K, Koivunen J, Kohtamäki L, Mäkelä S, Hernberg M. Mattila KE, et al. Acta Oncol. 2020 Mar;59(3):310-314. doi: 10.1080/0284186X.2019.1670862. Epub 2019 Sep 28. Acta Oncol. 2020. PMID: 31564175 No abstract available.

7

Limited-duration anti-PD-1 therapy for patients with metastatic melanoma.

Mäkelä S, Kohtamäki L, Laukka M, Juteau S, Hernberg M. Mäkelä S, et al. Acta Oncol. 2020 Apr;59(4):438-443. doi: 10.1080/0284186X.2020.1716388. Epub 2020 Jan 31. Acta Oncol. 2020. PMID: 32000554

8

Hepatic Ultrasonography Compared With Computed Tomography and Magnetic Resonance Imaging at Diagnosis of Metastatic Uveal Melanoma.

Rantala ES, Peltola E, Helminen H, Hernberg M, Kivelä TT. Rantala ES, et al. Am J Ophthalmol. 2020 Aug;216:156-164. doi: 10.1016/j.ajo.2020.03.049. Epub 2020 Apr 9. Am J Ophthalmol. 2020. PMID: 32278769 Free article.

9

Different expression of BRAFV600E, ALK and PD-L1 in melanoma in children and adolescents: a nationwide retrospective study in Finland in 1990-2014.

Rousi EK, Koskivuo IO, Juteau SM, Talve LAI, Hernberg MM, Vihinen PP, Kähäri VM. Rousi EK, et al. Among authors: hernberg mm. Acta Oncol. 2021 Feb;60(2):165-172. doi: 10.1080/0284186X.2020.1806358. Epub 2020 Aug 20. Acta Oncol. 2021. PMID: 32815748

10

Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma.

Rantala ES, Kivelä TT, Hernberg MM. Rantala ES, et al. Among authors: hernberg mm. Melanoma Res. 2021 Jun 1;31(3):224-231. doi: 10.1097/CMR.0000000000000728. Melanoma Res. 2021. PMID: 33595243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page